Efficacy and safety of weekly paclitaxel with or without ramucirumab as second-line therapy for the treatment of advanced gastric or gastroesophageal junction adenocarcinoma (RAINBOW-Asia): a randomised, multicentre, double-blind, phase 3 trial.

DOI:10.1016/S2468-1253(21)00313-7
作者：Rui-Hua Xu,?Yanqiao Zhang,?Hongming Pan,?Jifeng Feng,?Tao Zhang,?Tianshu Liu,?Yanru Qin,?Shukui Qin,?Xianli Yin,?Baorui Liu,?Yi Ba,?Nong Yang,?Pei Jye Voon,?Suebpong Tanasanvimon,?Chan Zhou,?Wan Li Zh
文献类型：期刊论文
补充材料：只需要正文